Months after chopping about a quarter of its US workforce, Sangamo Therapeutics is back with another round of layoffs to tighten its belt. As the Californian biotech closes down a facility in Brisbane early next year, it will be cutting another 40% of the remaining crew or 162 roles.
Sangamo…
Click here to view original post
